The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center;Tersiyer bir merkezde akut kalp yetersizlikli hastalarda hastane içi mortaliteye etkili faktörlerin belirlenmesi

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue 4, 2008, Pages 255-259

  Zoghi, Mehdi ^a   Duygu, Hamza ^a   Güngör, Hasan ^a   Nalbantgil, Sanem ^a   Yilmaz, Gülsüm Meral ^a   Tülüce, Kamil ^a   Özerkan, Filiz ^a   Akilli, Azem ^a   Akin, Mustafa ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acute heart failure; In hospital mortality; Logistic regression analysis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITROGEN; SODIUM; UREA;

ACUTE HEART FAILURE; ADULT; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; QRS COMPLEX; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; UREA NITROGEN BLOOD LEVEL;

BLOOD PRESSURE; BLOOD UREA NITROGEN; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CREATININE; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; HYPERTENSION; KIDNEY FAILURE; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SODIUM; SYSTOLE;

EID: 50249085371     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
2. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998; 19: 696-710.
3. Duygu H, Zoghi M, Nalbantgil S, Yaǧdi T, Akin M, Özbaran M, ve ark. Son dönem kalp yetersizliǧi nedeniyle kalp nakli bekleme listesine alinan hastalarda mortalite belirleyicileri. Türk Kardiyol Dern Arş 2005; 33: 149-54.
4. Cowie MR, Mosterd A, Wood DA, Poole-Wilson PA, Sutton GC, Grobbee DE. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-25.
5. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of heart failure epidemic findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 2002; 39: 60-9.
6. Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 2001; 80: 213-9.
7. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985-95. Am Heart J 1999; 137: 352-60.
8. Massie VM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133: 703-12.
9. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure. J Am Coll Cardiol 2003; 41: 1933-9.
10. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50.
11. Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP, et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002; 86: 225-31.
12. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290: 2581-7.
13. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ, for the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA 2005; 293: 572-80.
14. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002; 162: 1689-94.
15. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. ADHERE Scientific Advisory Committee Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-16.
16. Fonarow G, Abraham WT, Albert N, Gattis W, Gheorghiade M, Greenberg B, et al. Impact of evidence-based heart failure therapy use at hospital discharge on treatment rates during follow-up: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) (Abstract). J Am Coll Cardiol 2005; 45 (Suppl A): 345A (abstract)
17. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen Solal A, Aguilar JC, et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart failure survey programm - a survey on the quality of care among patients with heart failure in Europe. Eur Heart J 2003; 24: 442-63.
18. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, et al. Italian survey on Acute Heart Failure Investigators. Eur Heart J 2006; 27: 1207-15.
19. Rudiger A, Harjola VP, Muller A, Mattila E, Saila P, Neiminen M, et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail 2005; 7: 662-70.
20. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-67.
21. Gheorghiade M, Orlandi C, Burnett JC, DeMets D, Grinfeld L, Maggioni A, et al. Rationale and design of the multicenter, randomized, double-blind, placebo controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). J Card Fail 2005; 11: 260-9.
22. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, et al. OPTIME-CHF Investigators. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005; 111: 2454-60.
23. Chen MC, Chang HW, Cheng CI, Chen YH, Chai HT. Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 2003; 100: 136-42.
24. Adams KF, Zannad F, Hill C, France N. Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998; 135: 204-15.
25. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 2000; 102: 203-10.
26. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-6.
27. Palazzuoli A, Gallotta M, Iovine F, Nuti R, Silverberg DS. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anemia syndrome. Int J Clin Pract 2008; 62: 281-6.
28. Cohn J, Tognoni G, for the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-75.
29. Opasich C, Rapezzi C, Lucci D, Gorini M, Pozzar F, Zanelli E, et al. Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry). Am J Cardiol 2001; 88: 382-7.
30. Duygu H, Türk U, Zoghi M, Nalbantgil S. The importance of plasma B-type natriuretic peptide levels in cardiovascular diseases. Anadolu Kardiyol Derg 2005; 5: 305-11.
31. Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999; 70: 171-8.
32. Koga Y, Wada T, Toshima H, Akazawa K, Nose Y. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy. Heart Vessels 1993; 8: 37-41.
33. Ghali JK, Kadakia S, Bhatt A, Cooper R, Liao Y. Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure. Am Heart J 1992; 123: 993-7.
34. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 2004; 116: 300-4.
35. Chin MH, Goldman L. Correlates of major complication or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 1996; 156: 1814-20.
36. Rohde LE, Goldraich L, Polanczyk CA, Borges AP, Biolo A, Rabelo E, et al. A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail 2006; 12: 587-93.